PRECISION BIOSCIENCES INC (DTIL) Stock Income Statement
NASDAQ:DTIL - Nasdaq - US74019P2074 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 51.14M | 68.70M | 48.73M | 25.10M | 115.53M | |||
| Operating Expenses | 95.23M | 94.86M | 92.46M | 87.41M | 154.91M | |||
| Research and Development | 57.64M | 56.84M | 49.35M | 42.11M | 107.66M | |||
| Selling, General, and Administrative Expenses | 35.42M | 35.30M | 39.09M | 41.28M | 39.67M | |||
| Operating Income | -44.09M | -26.16M | -43.74M | -62.31M | -39.38M | |||
| Interest Income/Expense | 4.06M | 4.16M | 1.67M | 273.00K | 2.81M | |||
| Other Income/Expense | 18.42M | 29.61M | N/A | N/A | N/A | |||
| Non Recurring Items | N/A | N/A | 0.00 | -10.84M | 5.99M | |||
| Income Before Taxes | -21.99M | 7.17M | -42.53M | -72.91M | -30.60M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -21.99M | 7.17M | -61.32M | -111.64M | -30.60M | |||
| EBITDA | -41.43M | -22.76M | -36.92M | -54.51M | -30.39M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.01 | 1.04 | -15.96 | -38.10 | -15.64 | |||
| Non GAAP EPS | -2.01 | -0.15 | -16.06 | -42.00 | -20.40 | |||
| Statistics | ||||||||
| Profit Margin | -42.99% | 10.43% | -125.84% | -444.80% | -26.49% | |||
| Operating Profit Margin | -86.21% | -38.08% | -89.76% | -248.26% | -34.08% | |||
All data in USD